Skin & Pigmentation

Melanotan I

A melanocortin agonist; the approved form treats a rare light-sensitivity disorder.

What is Melanotan I?

Melanotan I is a melanocortin agonist that stimulates melanin production. Its clinically developed form, afamelanotide (Scenesse), is approved to reduce phototoxicity in people with erythropoietic protoporphyria (EPP).

Also known as: MT-1, Afamelanotide, Scenesse

Commonly researched for

Skin pigmentationPhotoprotectionEPP (approved use)

Research status

Approved (as afamelanotide) for a specific rare condition.

Important considerations

The approved form is prescription-only for EPP. Unregulated tanning use is not medically endorsed.

View published research on PubMed
This page is for educational purposes only and is not medical advice, a diagnosis, or a recommendation to use any compound. It contains no dosing or purchase information. Always consult a licensed healthcare professional before considering any peptide.